3.7 KiB
| type | title | author | url | date | domain | secondary_domains | format | status | priority | tags | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| source | Stagnating Declines in Cardiovascular Disease Mortality in the United States Expanded the Black-White Life Expectancy Gap | Leah R. Abrams, Nora Brower | https://pmc.ncbi.nlm.nih.gov/articles/PMC12560480/ | 2025-06-01 | health | research-paper | unprocessed | medium |
|
Content
Published in Preventive Medicine (ScienceDirect), June 2025. PMC12560480. Authors: Leah R. Abrams, Nora Brower (same researchers as the AJE "pervasive stagnation" paper).
Key findings:
- In 2000–2009, CVD mortality was declining faster for Black Americans, and the Black-White life expectancy gap NARROWED by 1.39 years (women) and 1.44 years (men).
- After 2010, this progress stalled. The CVD stagnation disproportionately LIMITED longevity gains for Black Americans, especially Black women.
- Counterfactual: Had pre-2010 CVD trends continued through 2019, Black women would have lived 2.04 years longer, narrowing the Black-White gap by 0.43 years.
- If trends had continued through 2022: Black women would have lived 2.83 years longer, closing the gap by 0.64 years.
- COVID-19 pandemic reversed some of these gains, with CVD mortality rising especially for Black Americans during the pandemic.
Key insight: The convergence in racial health disparities that occurred 2000-2010 was primarily driven by CVD mortality improvements — and the stagnation post-2010 stopped that convergence. What appeared to be a diversity/equity problem is actually a structural cardiovascular disease problem.
Agent Notes
Why this matters: This adds the racial disparity dimension to the structural CVD stagnation story. The 2010 CVD stagnation didn't just plateau national life expectancy — it specifically reversed progress on racial health equity. This is a second-order effect of the structural failure identified in the AJE paper. What surprised me: The convergence finding (2000-2010 gap narrowing was CVD-driven) means that CVD stagnation is actually a racial equity issue, not just a population-level health issue. The equity progress of the 2000s was not sustained through policy or social change but through CVD improvements that then stopped. What I expected but didn't find: Evidence that specific interventions are reversing the post-2010 stagnation for Black Americans. The counterfactual analysis suggests a structural fix (CVD improvement) would have more impact than targeted equity programs. KB connections: Connects Belief 1 (structural deterioration) with Belief 3 (misaligned incentives — VBC claims to address health equity but structural CVD driver isn't being addressed); links to SDOH claims. Extraction hints: "CVD stagnation after 2010 reversed a decade of Black-White life expectancy gap narrowing — structural cardiovascular failure is the primary driver of persistent racial health disparities, not demographic or social factors alone." Context: Companion to AJE "pervasive stagnation" paper by the same authors. Provides the equity/disparity angle to the same underlying CVD stagnation mechanism.
Curator Notes
PRIMARY CONNECTION: AJE "Pervasive Stagnation" paper (companion by same authors); SDOH/health equity claims in KB WHY ARCHIVED: Provides equity dimension of CVD stagnation — shows structural CVD failure is the primary mechanism behind persistent racial health disparities EXTRACTION HINT: The claim that CVD stagnation stopped racial health convergence is important for the "structural vs. social determinants" debate — structural CVD improvement produces equity outcomes that explicit equity programs don't.